# Tazorac

NDC: 16110-833
Generic name: tazarotene
Labeler / Manufacturer: Almirall, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: CUTANEOUS
Marketing started: 20200221

FDA application: NDA020600

## Active ingredients

- TAZAROTENE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16110-833"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16110-833
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e4e4b81-420e-4492-8a74-80b692a80057